MaldekChin — Tree of Knowledge
Maldek·CHIN
← Pathophysiology library
Clinician view

Pathophysiology

IBD

Ask the Tutor

Barrier Breach: The IBD Engine

Why does the body start a civil war with its own plumbing? You are looking at a system that forgot how to distinguish 'self' from 'non-self' at the most crowded border in the body.

The central question: Why is the immune system attacking the intestinal wall?

01

How it works — the zoom from whole body to molecule

System to cell

  1. 1

    System

    the whole body at work

    • In a healthy gut, the mucosal barrier acts as a high-security border fence, keeping the trillions of bacteria in the lumen away from the systemic circulation.
    • Tight junctions hold epithelial cells together while a thick mucus layer prevents direct contact, and specialized T-regulatory cells ensure the immune system tolerates 'good' bacteria.
    • This balance allows for nutrient absorption and waste transport without triggering an inflammatory alarm.
  2. 2

    Organ

    the healthy sequence, step by step

    • Selective barrier integrity via tight junctions
    • Protective mucus layer secretion
    • Immune tolerance of commensal bacteria
    • Controlled nutrient and water absorption
  3. 3

    Tissue & mechanism

    where and why it breaks

    • The central pathway of IBD is a dysregulated cytokine cascade fueled by an overactive T-cell response.
    • Dendritic cells sample antigens from the lumen and inappropriately activate Th1 and Th17 cells, which then flood the tissue with TNF-alpha to recruit more 'soldiers' (leukocytes).
    • These leukocytes travel through the bloodstream and use specific 'keys' (integrins) to enter the gut tissue, where they release oxidative bursts that cause the actual ulceration and pain.
  4. 4

    Cell & molecule

    the break at its smallest scale

    • Antigen presentation to naive T-cells
    • Pro-inflammatory cytokine signaling (TNF, IL-12/23)
    • Upregulation of adhesion molecules (integrins) for leukocyte trafficking
    • Infiltration of effector cells into the intestinal wall
    • Chronic tissue remodeling and ulceration
  5. 5

    The result

    what the break produces

    • Loss of immune tolerance and mucosal barrier integrity
    • Antigen penetration into the lamina propria
    • Massive release of pro-inflammatory cytokines (TNF-alpha, IL-12, IL-23)
    • Recruitment of aggressive T-cells to the gut wall
02

How it works when healthy

Normal anatomy & physiology

  • In a healthy gut, the mucosal barrier acts as a high-security border fence, keeping the trillions of bacteria in the lumen away from the systemic circulation.
  • Tight junctions hold epithelial cells together while a thick mucus layer prevents direct contact, and specialized T-regulatory cells ensure the immune system tolerates 'good' bacteria.
  • This balance allows for nutrient absorption and waste transport without triggering an inflammatory alarm.

The healthy sequence

  1. 1Selective barrier integrity via tight junctions
  2. 2Protective mucus layer secretion
  3. 3Immune tolerance of commensal bacteria
  4. 4Controlled nutrient and water absorption
03

Why it breaks

The mechanism

  • The central pathway of IBD is a dysregulated cytokine cascade fueled by an overactive T-cell response.
  • Dendritic cells sample antigens from the lumen and inappropriately activate Th1 and Th17 cells, which then flood the tissue with TNF-alpha to recruit more 'soldiers' (leukocytes).
  • These leukocytes travel through the bloodstream and use specific 'keys' (integrins) to enter the gut tissue, where they release oxidative bursts that cause the actual ulceration and pain.

Step by step

  1. 1Antigen presentation to naive T-cells
  2. 2Pro-inflammatory cytokine signaling (TNF, IL-12/23)
  3. 3Upregulation of adhesion molecules (integrins) for leukocyte trafficking
  4. 4Infiltration of effector cells into the intestinal wall
  5. 5Chronic tissue remodeling and ulceration
04

The failure chain

Pathophysiology of dysfunction

  • IBD begins when the mucosal barrier fails or the immune system becomes hyper-sensitive to normal gut flora, leading to a massive influx of inflammatory cells.
  • Once the 'fence' is breached, the body treats its own gut lining like an invading pathogen, triggering a self-sustaining cycle of tissue destruction.
  • This shift turns a quiet processing plant into a battlefield of ulcers, abscesses, and scarring.

The first thing to break

Loss of immune tolerance and mucosal barrier integrity

The cascade, in order

  1. 1Antigen penetration into the lamina propria
  2. 2Massive release of pro-inflammatory cytokines (TNF-alpha, IL-12, IL-23)
  3. 3Recruitment of aggressive T-cells to the gut wall
  4. 4Transmural (Crohn's) or mucosal (UC) tissue destruction
05

Normal → Compensation → Decompensation → Failure

The full arc

1

Compensation

What you see

  • Increased stool frequency
  • Mild urgency
  • Low-grade fatigue

What fools you

The patient looks okay, but the gut is working overtime to absorb water through an increasingly leaky and inflamed surface.

2

Decompensation

What you see

  • Bloody diarrhea
  • Weight loss
  • Systemic inflammatory response (tachycardia/fever)
3

Failure

What you see

  • Toxic Megacolon
  • Perforation
  • Multi-organ dysfunction

What dies

The intestinal wall loses all tone and integrity, leading to a massive leak of bacteria into the peritoneum and systemic shock.

The 'Stool vs. Serum' Check

If the CRP (serum) is low but Calprotectin (stool) is high, the fire is localized to the gut; if both are high, the system is crashing. This tells you if you're treating an organ or a whole patient.

Pitfall: Assuming a patient isn't 'that sick' because their labs look okay, when their gut wall is actually thinning toward perforation.

06

Tied to the mechanism

Why the symptoms appear

The chain that produces them

  1. 1Antigen penetration into the lamina propria
  2. 2Massive release of pro-inflammatory cytokines (TNF-alpha, IL-12, IL-23)
  3. 3Recruitment of aggressive T-cells to the gut wall
  4. 4Transmural (Crohn's) or mucosal (UC) tissue destruction

What surfaces at each stage

Compensation

  • Increased stool frequency
  • Mild urgency
  • Low-grade fatigue

Decompensation

  • Bloody diarrhea
  • Weight loss
  • Systemic inflammatory response (tachycardia/fever)

Failure

  • Toxic Megacolon
  • Perforation
  • Multi-organ dysfunction
07

Each drug → the exact broken step it fixes

What the medications do

Aminosalicylates (5-ASA)

interrupts: Local prostaglandin and leukotriene synthesis
  • These act like a topical soothing balm for the inner lining of the gut.
  • They are first-line for mild-to-moderate UC because they shut down the local chemical signals of heat and swelling.
  • A clinician should evaluate for renal function before starting, as they are excreted by the kidneys.

Corticosteroids

interrupts: Global cytokine transcription
  • This is the 'sledgehammer' that shuts down the entire immune response at the nuclear level.
  • Use these to induce remission in a flare, but never for long-term maintenance due to systemic side effects like bone loss and adrenal suppression.
  • They stop the fire but don't fix the house.

Anti-TNF agents (Infliximab/Adalimumab)

interrupts: TNF-alpha signaling pathway
  • By neutralizing TNF-alpha, you are intercepting the primary '911' signal that recruits more inflammatory cells to the gut.
  • This halts the cascade before the damage gets out of hand.
  • A clinician must confirm negative TB and Hep B status before initiation to avoid catastrophic reactivation.

Anti-Integrins (Vedolizumab)

interrupts: Leukocyte trafficking/migration
  • This is gut-selective traffic control; it blocks the 'key' that T-cells use to enter the gut tissue from the blood.
  • Since it only works in the gut, it avoids the systemic immunosuppression seen with other biologics.
  • It is a precise strike rather than carpet bombing.

IL-12/23 Inhibitors (Ustekinumab)

interrupts: Th1 and Th17 cell differentiation
  • These drugs target the 'upstream' instructions that tell the immune system to become aggressive in the first place.
  • By blocking these interleukins, you prevent the maturation of the cells that drive chronic inflammation.
  • This is often used when TNF-inhibitors fail.
08

Confirm it, track it, act on it

Labs & outcomes

  • Labs assess activity + nutrition + infection.
CBC + iron studiesCommon; treat

Iron deficiency anemia (chronic blood loss)

ESR + CRPTrack response to therapy

Disease activity

Fecal calprotectinDistinguishes IBD from IBS

Inflammation marker (more specific than CRP)

Stool studies (C. diff, culture, ova/parasites)Before steroid escalation

Rules out infection (and infection complicating flare)

Albumin + vitamin levelsReplete

Malnutrition + B12 (terminal ileum disease)

LFTsAlk phos elevation

PSC (sclerosing cholangitis) screen, esp. UC

Quantiferon-TB before biologicMandatory

Prevents TB reactivation

Interventions

5-ASA (mesalamine) PO + topicalMild-moderate UC

First-line for mild-moderate UC

BudesonideMild-moderate Crohn's (ileocecal)

First-line for mild-moderate ileocecal Crohn's

Prednisone for moderate-severe flareBridge therapy

Not for maintenance

Azathioprine or methotrexateSteroid-sparing immunomodulator

Maintenance

Anti-TNF (infliximab, adalimumab)Moderate-severe IBD

First-line biologic

Vedolizumab (anti-α4β7) or ustekinumab (anti-IL-12/23)TNF failure

Alternative mechanisms

JAK inhibitors (tofacitinib, upadacitinib)Refractory UC

Oral targeted

Surgical resectionStricture, fistula, refractory, dysplasia/cancer

Sometimes curative for UC

What this means at the bedside

Anticipate: Screen for malnutrition and bone density early; the disease and the treatments both steal from the patient's structural reserves.

Watch for: A sudden rigid abdomen or 'silent' bowel sounds in a patient with a known flare; this is the sound of an impending surgical emergency.

Uncertainty: The precise environmental or microbial 'trigger' that starts the initial barrier breach remains unknown and varies by patient.

References

← Back to the Pathophysiology library

Educational use onlyThis system is for educational and clinical decision-support purposes only. It does not provide medical advice, diagnosis, or treatment. Crisis supportPrivacyTerms

Adapted with permission from the Clinical Reasoning Loop™, part of the Think Like a Provider™ Clinical Reasoning System by Jennawè Whitley, APRN, FNP-BC, NP-C. © Capital Covenant Enterprise LLC.

Install Maldek CHIN as an app — studies work even offline